Literature DB >> 2702724

Detection and measurement of MeIQx in human urine after ingestion of a cooked meat meal.

S Murray1, N J Gooderham, A R Boobis, D S Davies.   

Abstract

A gas chromatographic-mass spectrometric assay has been developed for the measurement of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in urine. The method employs capillary column gas chromatography, electron capture negative-ion chemical ionization mass spectrometry, a stable isotope-labelled analogue of MeIQx as internal standard and has a limit of detection of 5 pg MeIQx/ml urine. Six subjects consumed a fried beef meal and urine was collected before and after this event. While no MeIQx could be detected in urine collections made prior to meat consumption, the 12-h urine collections of all six subjects made after the meal contained the amine. When the amounts of MeIQx measured in the urine collections were compared to the quantities of amine ingested in the fried beef, it was found that 1.8-4.9% of the oral dose was excreted unchanged in urine. Metabolic studies in animals lead us to believe that MeIQx in the diet is efficiently absorbed and extensively biotransformed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2702724     DOI: 10.1093/carcin/10.4.763

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

1.  Sensitive quantitative assay for point mutations in the rat H-ras gene based on single nucleotide primer extension.

Authors:  Yoshihisa Yano; Tomohiro Yano; Anna Kinoshita; Ai Matoba; Tadayoshi Hasuma; Hideki Wanibuchi; Keiichirou Morimura; Shuzo Otani; Shoji Fukushima
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

Review 2.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

3.  Caffeine Cytochrome P450 1A2 Metabolic Phenotype Does Not Predict the Metabolism of Heterocyclic Aromatic Amines in Humans.

Authors:  Robert J Turesky; Kami K White; Lynne R Wilkens; Loïc Le Marchand
Journal:  Chem Res Toxicol       Date:  2015-08-06       Impact factor: 3.739

Review 4.  Perspectives on the chemical etiology of breast cancer.

Authors:  Lillian S DeBruin; P David Josephy
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

5.  Lack of carcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in cynomolgus monkeys.

Authors:  K Ogawa; H Tsuda; T Shirai; T Ogiso; K Wakabayashi; D W Dalgard; U P Thorgeirsson; S S Thorgeirsson; R H Adamson; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1999-06

6.  Metabolism of the food-borne carcinogens 2-amino-3-methylimidazo-[4,5-f]quinoline and 2-amino-3,8- dimethylimidazo[4,5-f]-quinoxaline in the rat as a model for human biomonitoring.

Authors:  R J Turesky; W G Stillwell; P L Skipper; S R Tannenbaum
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

7.  Exposure to heterocyclic amines.

Authors:  K Wakabayashi; H Ushiyama; M Takahashi; H Nukaya; S B Kim; M Hirose; M Ochiai; T Sugimura; M Nagao
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

8.  Species differences in metabolism of heterocyclic aromatic amines, human exposure, and biomonitoring.

Authors:  R J Turesky; G A Gross; W G Stillwell; P L Skipper; S R Tannenbaum
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

9.  Gas chromatography-mass spectrometry analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in urine and feces.

Authors:  M D Friesen; L Garren; J C Béréziat; F Kadlubar; D Lin
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

10.  Hepatocellular carcinoma induction in LEC rats by a low dose of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.

Authors:  H Sone; K Wakabayashi; H Kushida; K Enomoto; M Mori; N Takeichi; H Tsuda; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1996-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.